Pharmacogenetic investigation of pyrexia in patients treated with dabrafenib alone or in combination with trametinib from five melanoma studies
Kulkarni, Diptee A, Song, Kijoung, Briley, Linda P, King, Karen S, Dabrowski, Christine Ellen, Del Buono, Heather Lynn, Mookerjee, Bijoyesh, Legos, Jeffrey J., Spraggs, Colin F.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Updated overall survival (OS) results for BRF113220, a phase I–II study of dabrafenib alone versus combined dabrafenib and trametinib in patients with BRAF V600 metastatic melanoma (MM)
Daud, Adil, Weber, Jeffrey S., Sosman, Jeffrey Alan, Kim, Kevin, Gonzalez, Rene, Hamid, Omid, Infante, Jeffrey R., Cebon, Jonathan S., Schuchter, Lynn Mara, Long, Georgina V., Algazi, Alain Patrick, Kudchadkar, Ragini Reiney, Puzanov, Igor, Lawrence, Donald P., Kefford, Richard, Kline, Amy S., Del Buono, Heather Lynn, Sun, Peng, McDowell, Diane Opatt, Flaherty, Keith
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article